Cargando...
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
Cardiac amyloidosis is a restrictive cardiomyopathy that results from the deposition of misfolded light chain or transthyretin proteins, most commonly, in cardiac tissue. Traditionally, treatment options for light chain (AL) and transthyretin (ATTR) amyloidosis have been limited. However, there are...
Gardado en:
| Publicado en: | JACC Basic Transl Sci |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609907/ https://ncbi.nlm.nih.gov/pubmed/31312767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2019.02.002 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|